Post by ABX-CRO advanced pharmaceutical services Forschungsgesellschaft

We’re delighted to visit the Australian and New Zealand Society of Nuclear Medicine #ANZSNM 56th Annual Scientific Meeting from 15-17 May 2026 in #Canberra for the first time as a commitment to the Australian RLT development. The combination of regulatory efficiency, cost-effectiveness, and high scientific quality has positioned Australia as one of the leading destinations for early clinical development. With our extensive expertise in scientifically focussed early phase development, we are locally present to provide our customers with scientific consultancy and strategic guidance. Moritz Kallerhoff and Felix Husmann, PMP look forward to productive discussions about planning early-phase clinical trials. Get in touch with them to set up a meeting or contact our Office Management Team: 📞  +49 351 21 444 0 📧  [email protected] #EarlyPhaseTrials #CROServices #radiopharmaceuticals #theranostics #dosimetry